Hamps Bio Limited (BOM:544312)

Market Cap	219.98M
Revenue (ttm)	71.20M +3.0%
Net Income	-1.63M
EPS	-0.14
Shares Out	8.71M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,000
Average Volume	14,200
Open	25.25
Previous Close	25.68
Day's Range	25.25 - 25.25
52-Week Range	13.36 - 35.00
Beta	n/a
RSI	64.91
Earnings Date	May 26, 2026

About Hamps Bio

Hamps Bio Limited provides pharmaceutical, freeze dried, and frozen products in India and internationally. The company offers nutrition supplement, injection, pediatric care, toothpaste, mouth wash, antiacid/PPI, painkiller/anti-inflammatory, hematantic/calcium supplement, and antibiotic/antibacterial/antifungal pharmaceutical products. It also offers dry freeze food products, including ready to eat food, juices, ice cream powder, smoothie, tea, fruit snacks, milk related, and other dry food products. The company sells its products under the HA...

• Industry: Pharmaceutical Preparations
• Founded: 2007
• Employees: 75
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 544312

Financial Performance

In fiscal year 2025, Hamps Bio's revenue was 66.69 million, an increase of 2.99% compared to the previous year's 64.75 million. Earnings were 2.98 million, a decrease of -40.53%.